LexaMed
LexaMed is a Toledo, Ohio-based contract testing laboratory providing USP-method microbiology, sterility, endotoxin, particulate, sterilization validation, and packaging integrity testing services to medical device and pharmaceutical manufacturers, complemented by technical consulting.
- Company typePrivate
- Founded2006
- HeadquartersToledo, United States
- Headcount11–50
- GTM typeB2B
- OfferingServices
What LexaMed does
LexaMed is a privately held contract testing laboratory headquartered in Toledo, Ohio, founded in 2006, that provides microbiology, analytical chemistry, sterilization validation, environmental monitoring, and packaging integrity testing services to medical device and pharmaceutical manufacturers. Its core offering spans Medical Device Lot Release Testing, Pharmaceutical Lot Release Testing, and Technical Consulting Services, supported by a broad menu of specialized tests including USP <71> sterility, USP <85> bacterial endotoxin, bioburden, particulate testing per USP <788>/<789>, cytotoxicity, D-value verification using BIER units, microbial stability studies, and reusable medical device cleaning/sterilization validations. The company also publishes standardized turnaround times (e.g., 7-day endotoxin, 10-day bioburden, 8–15-day sterility) and advertises a 99.99% error-free report rate, indicating a routine-testing layer alongside bespoke validation work.
The business operates as a sales-led contract laboratory, serving two primary verticals (medical device manufacturers and pharmaceutical manufacturers) with a quote-based engagement model and direct client portal access. LexaMed holds ISO 13485 certification, ISO 17025 accreditation (valid through 2027), DEA Controlled Substance registration, FDA establishment registration, and a State of Ohio Drug License, positioning it to bid on regulated testing work. The company is independently owned, with no disclosed parent company, private equity backing, or institutional investment identified in the source material.
Revenue mechanics are not publicly disclosed. With 11–50 employees, a nearly two-decade operating history, and an active service expansion cadence (routine SLAs, MSS, BIER D-value), LexaMed appears to be a stable mid-sized regional lab rather than a high-growth venture-backed operator. No funding rounds, acquisitions, leadership changes, or geographic expansions are documented in the available data.
LexaMed firmographics
Firmographics- Name
- LexaMed
- Legal name
- LexaMed
- Website
- https://lexamed.com
- Company type
- Private
- Founded year
- 2006
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- LexaMed is a Toledo, Ohio-based contract testing laboratory providing USP-method microbiology, sterility, endotoxin, particulate, sterilization validation, and packaging integrity testing services to medical device and pharmaceutical manufacturers, complemented by technical consulting.
- Ownership category
- akta.pro rank
LexaMed industry classification
Industry- Product category
- Contract Laboratory Testing Services
- NAICS
- Testing Laboratories and Services (541380)
- SIC
- Services-Medical Laboratories (8071), Services-Commercial Physical & Biological Research (8731)
- akta.pro primary industry
- Analytical Testing & QC Release Services (potency, purity, sterility) (HLAAAKAG)
- akta.pro secondary industry
- Microbiology & Sterility Assurance (Bioburden/Endotoxin/Sterility) (HLAGADAE)
Keywords
Where LexaMed is headquartered
LocationHeadquarters
- HQ city
- Toledo
- HQ country
- United States
- HQ region
- North America
Markets served
LexaMed business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Technology or R&D, Infrastructure, Marketing or Sales, Supply Chain
Go-to-market motion1 record
Distribution channels1 record
Marketing channels1 record
LexaMed product offering
Product offeringCore offering
LexaMed provides contract laboratory testing services to medical device and pharmaceutical manufacturers, covering lot release testing (sterility, endotoxin, bioburden, particulates), microbiology, analytical chemistry, sterilization validations, environmental monitoring, package integrity testing, and reusable device cleaning and sterilization validations. The company complements these laboratory services with technical consulting in regulatory assistance, quality management, and compliance auditing.
Product overview
LexaMed is a contract laboratory and consulting company providing medical device and pharmaceutical manufacturers with comprehensive laboratory testing services complemented by technical consulting. The core offerings include Medical Device Lot Release Testing, Pharmaceutical Testing Services, and Technical Consulting Services. Testing services span across multiple specialized modules including Microbiology Testing, Particulate Testing, Cytotoxicity Testing, Analytical Chemistry Testing, Sterilization Validations, Environmental Monitoring, and Package Integrity Testing. Specialized studies include Microbial Stability Studies (MSS), D-value Verifications, and Reusable Medical Device Validations. The company also offers Routine Testing services for sterility, endotoxin, and bioburden with specific turnaround times. All services are supported by ISO 13485 certification and ISO 17025 accreditation.
Differentiator
Problem solved
Functional benefit
Products and services
- Medical Device Lot Release Testing
Quantifiable outcome
- Reports are published 99.99% error free
Companies that use LexaMed
Customer profileSegments2 records
Ideal customer profiles2 records
LexaMed technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature7 records
LexaMed partnerships and signals
Strategic signalRecent moves5 records
Expansion highlights4 records
LexaMed competitors and assessment
Company assessmentBroad incumbents
- Eurofins Scientific: Global testing services conglomerate with extensive pharmaceutical and medical device testing capabilities across hundreds of sites; competes with LexaMed on sterility, endotoxin, and microbiological release testing but with far broader scope and scale.
- Intertek: Global TIC provider with pharmaceutical services including sterility, endotoxin, and microbiological testing as part of its wider industrial and consumer products testing business — overlaps with LexaMed on regulated lab services.
- Charles River Laboratories: Major global CRO/CDMO with an established contract testing and manufacturing services business serving pharmaceutical and medical device manufacturers across release testing, microbiology, and biologics safety — overlapping with LexaMed in pharma QC testing.
- WuXi AppTec: Large China-headquartered CRO/CDMO offering laboratory testing and bioanalytical services for pharmaceutical and medical device manufacturers — competes with LexaMed for pharma QC testing work, particularly for clients with global sourcing needs.
- Pace Analytical: Large US-based testing laboratory network offering life sciences, environmental, and pharmaceutical testing services — competes with LexaMed on pharmaceutical and medical device release testing with broader geographic reach.
- SGS: Global testing, inspection, and certification company with a life sciences vertical offering pharmaceutical and medical device testing services — competes with LexaMed for outsourced QC and validation work, though as part of a far broader portfolio.
Direct peers
- MicroTest Laboratories: Massachusetts-based contract testing lab focused on medical device and pharmaceutical microbiology, sterilization validation, and package integrity — closely mirrors LexaMed's niche and serves a comparable customer base.
- Nelson Laboratories: Salt Lake City–based contract laboratory specializing in medical device and pharmaceutical microbiological and analytical testing, including sterility, endotoxin, bioburden, and packaging integrity — directly overlaps LexaMed's core service menu and customer base.
- Toxikon: Massachusetts-based preclinical and medical device testing laboratory offering extractables/leachables, biocompatibility, and toxicology testing — directly comparable niche contract lab serving medical device manufacturers, now operating under Labcorp Drug Development.
- Pacific Biolabs: California-based contract laboratory providing medical device and pharmaceutical testing including sterility, endotoxin, bioburden, cytotoxicity, and reusable device validations — directly comparable to LexaMed's USP compendial and validation portfolio.
Market position
Strengths4 records
Weaknesses5 records
Competitive moat4 records
Key risks6 records
Key highlights6 records
Customer concentration
LexaMed social profiles
Digital presenceLexaMed compliance and trust
Trust signalCompliance5 records
LexaMed financial estimates
Financial estimateRevenue estimate
Valuation estimate
LexaMed leadership team
Management profileNumber of profiles
LexaMed funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
LexaMed M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about LexaMed
What does LexaMed do?
LexaMed provides contract laboratory testing services to medical device and pharmaceutical manufacturers, covering lot release testing (sterility, endotoxin, bioburden, particulates), microbiology, analytical chemistry, sterilization validations, environmental monitoring, package integrity testing, and reusable device cleaning and sterilization validations. The company complements these laboratory services with technical consulting in regulatory assistance, quality management, and compliance auditing.
Is LexaMed a public or private company?
LexaMed is a private company. It is classified as unknown and is currently operating.
When was LexaMed founded?
LexaMed was founded in 2006. It employs 11 to 50 people.
Where is LexaMed based?
LexaMed is headquartered in Toledo, United States, in the North America region.
Who are LexaMed's main competitors?
Broad incumbents on record are Eurofins Scientific, Intertek, Charles River Laboratories, WuXi AppTec, Pace Analytical and SGS. Direct peers are MicroTest Laboratories, Nelson Laboratories, Toxikon and Pacific Biolabs.
Does LexaMed have an API?
No public API is recorded for LexaMed.
What industry is LexaMed in?
LexaMed's product category is Contract Laboratory Testing Services. Its primary akta.pro industry code is HLAAAKAG, Analytical Testing & QC Release Services (potency, purity, sterility), with a secondary code of HLAGADAE, Microbiology & Sterility Assurance (Bioburden/Endotoxin/Sterility). Its NAICS code is 541380 and its SIC code is 8071.